Lessons for Delhi: How China cut PM2.5 emissions by 33% in 5 yrs

NEW DELHI: A new Lancet study on the impact of China’s Air Pollution Prevention and Control Action Plan (2013-2017) could be a document of interest to a city like Delhi that is struggling to fight pollution.

The study

The study by Peking University School of Public Health found that annual average concentration of PM2.5 decreased by 33.3% in 74 key cities where the plan was implemented in the last five years.

Researchers found that PM10 levels reduced by 27.8%, sulphur dioxide (SO2) by 54.1% and carbon monoxide (CO) by 28.2% in five years, but no significant improvements were seen in nitrogen dioxide (NO2) or ozone (O3) concentrations.

Lessons for Delhi: How China cut PM2.5 emissions by 33% in 5 yrs
Fewer pollution-linked deaths

This reduction may have led to 44,240 fewer air pollution-linked deaths in 74 Chinese cities in the Beijing-Tianjin-Hebei region, the Yangtze River Delta region, and the Pearl River Delta region, according to the study.

“To our knowledge, this is the first study to comprehensively evaluate the long-term health impact of China’s air pollution control policy at the national level. Appreciable reductions in concentrations of air pollutants were observed from 2013 to 2017… the APPCAP in China is similar to the Clean Air Act. It sets quantitative air quality improvements goals for key regions within a clear time limit and lists 10 key actions covering all major aspects of air quality management,” the study stated.

It concluded that though direct comparisons of its effects with those of Clean Air Acts in the UK and the US were difficult because the APPCAP was only introduced in 2013, a key strength of the legislation was that it demonstrated China’s ability to control air pollution.

In 2013, it was estimated that the health loss due to PM2.5 pollution in the 74 leading cites in China was 4.2 lakh premature deaths, which included 64, 810 cases of COPD, nearly a lakh cases of ischaemic heart disease and 55,360 cases of lung cancer. In 2017, the estimates decreased to 3.65 lakh premature deaths attributable to PM 2.5 pollution, which comprised 50,470 cases of COPD, 97,790 cases of ischaemic heart disease and 43,000 cases of lung cancer.

Researchers used annual air pollution concentration data from China Statistical Yearbook and mortality data from the China Centers for Disease Control and Prevention. Since 2004, the China Centers for Disease Control and Prevention has established 161 death surveillance points. According to the China Statistical Yearbook, these 74 cities assessed contributed to 63% of the country’s GDP in 2013.

What Delhi can learn

Union environment secretary CK Mishra recently said the National Clean Air Programme (NCAP) would have three timelines to gradually reduce air pollution and bring it down by 70-80% from the current levels in 10 years. Under the timelines, air pollution in these cities — Delhi, Mumbai, Pune, Kolkata, Bengaluru, Chandigarh, Allahabad, Varanasi, Kanpur, Jaipur and Patna, among others — will be reduced by 35% in the next three years, 50% in the next five and 70-80% in the next 10 years.

No time-bound targets for NCR

The plan may come in to force from August 15 this year, but the latest NCAP isn’t yet in public domain. Experts say NCAP document requires an effective compliance strategy to meet targets like China did. In fact, the “Comprehensive Action Plan (CAP) for Air Pollution Control in Delhi and NCR”, which has been notified by the Union environment ministry under Section 5 of the environment protection Act, doesn’t have any time-bound targets.

The SC-mandated EPCA had suggested a reduction of 69.7% in PM2.5 concentrations and 74% in PM10 concentrations is needed in Delhi and NCR to meet the annual average safe standard in the draft comprehensive plan. But these targets were not included in the notified version at all.

“I think the message is clear. We need clear air pollution control targets and a plan to meet them. The process has to be verifiable similar to how China has done it. The level of stringency needs to be very high and it should be monitored at every milestone and verify whether it’s on track. The notified version of CAP doesn’t have targets. How do you calibrate the plan if there are no verifiable targets?” asked Anumita Roy Chowdhury, executive director, Centre for Science and Environment.

  • Related Posts

    Chandigarh News: Dibar Pharmaceutical Company Misled PGI Through Fake Letter, Case Registered – Dibar Pharmaceutical Company Misled PGI Through Fake Letter, Case Registered

    Chandigarh:  A case has been registered against a pharmaceutical company for trying to mislead PGI by creating a fake letter from CDSCO (Central Drugs Standard Control Organisation) Baddi to prove…

    Kushinagar News: Truck Was Traveling From Ghaziabad To Agartala, Mystery Revealed When It Overturned

    Case of codeine syrup being hidden among sugar sacks in a truck. After receiving the documents, the pharmaceutical department sent them to Ghaziabad and Agartala and started investigation. Kushinagar/Rahsu Bazaar.…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Regular Supplier Of Stents Ignored By Doctors Due To Low Commission; Company Supplying Despite Crores Of Dues

    Regular Supplier Of Stents Ignored By Doctors Due To Low Commission; Company Supplying Despite Crores Of Dues

    ACB Gujarat Nabs Female Drug Inspector In A Bribe Case

    ACB Gujarat Nabs Female Drug Inspector In A Bribe Case

    Netherlands: Health Secy Visits Bilthoven Biologicals, Discusses Collaboration On Production Of Oral Polio Vaccine

    Netherlands: Health Secy Visits Bilthoven Biologicals, Discusses Collaboration On Production Of Oral Polio Vaccine

    India Lifts Safeguard Measures On Isopropyl Alcohol Imports

    India Lifts Safeguard Measures On Isopropyl Alcohol Imports

    Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

    Punjab And Haryana HC Notice To Centre On Petition Against Misuse Of Oxytocin

    Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines

    Nepal Drugs Regulator To Conduct On-Site Testing Of Medicines